Slowing Macular Degeneration with Photobiomodulation (PBM) Therapy
Age-Related Macular Degeneration (AMD) is a leading cause of vision loss, particularly the “dry” form, in which cellular debris (drusen) accumulates under the retina. Until recently, treatments for dry AMD were limited to nutritional supplements. Today, Paul Vision Institute offers Photobiomodulation (PBM) using the Valeda® Light Delivery System. This FDA-cleared technology uses specific wavelengths of light to improve cellular function and slow disease progression for our North Carolina seniors.
Photobiomodulation works at the mitochondrial level. The Valeda system delivers low-level red, yellow, and near-infrared light to the retinal cells. These wavelengths are absorbed by an enzyme called cytochrome c oxidase, which triggers an increase in energy production (ATP) and reduces oxidative stress. By revitalizing these “stressed” cells, PBM helps the retina process waste more efficiently, potentially reducing the accumulation of drusen and preserving the central vision required for reading and driving.
This treatment is non-invasive and does not require injections. Each session takes less than 5 minutes per eye, and a full course typically involves 9 treatments over 3 weeks. For our patients in Wilmington and the surrounding coastal communities, PBM represents a proactive, high-tech way to guard against the vision loss that once seemed inevitable with dry AMD.
FAQ: Understanding PBM for AMD
- Is this a cure for AMD? While not a cure, clinical trials have shown that PBM can improve vision scores and slow disease progression in many patients.
- Does it hurt? No. The treatment involves looking at a series of flickering lights. It is completely painless and requires no recovery time.
- How do I know if I’m a candidate? PBM is most effective for patients with early-to-intermediate “dry” macular degeneration. We perform a thorough retinal scan to determine if you are a fit.
- Is it safe? Yes, PBM has a high safety profile and does not cause the thermal damage associated with surgical lasers.




